GSK hopes to grow in all three of its business areas – consumer healthcare, pharmaceuticals and vaccines – in India with product introductions and a strategy to expand further into rural markets. CEO Andrew Witty previously headed Glaxo’s Asia Pacific operations and says he is a “huge bull on India.”
GlaxoSmithKline PLC’sbest-case scenario for growth in India includes building capacity for its consumer business there, CEO Andrew Witty says.
During a recent discussion Glaxo board members and executives conducted in New Delhi with a panel of Indian finance and...